In addition, we found that TG levels in HepG2 cells were not reduced by NaB intervention alone but were markedly reduced by the combination of NaB with GLP-1, suggesting that NaB alleviated hepatic steatosis partially through enhancing GLP-1 action
The STEP trial data in detail Understanding the clinical trial evidence gives you a realistic baseline for what to expect
Sabba, C., Berardi, E., Antonica, G., Ferraioli, G., Buonamico, P., Godi, L., Brevetti, G., and Albano, O
doi: 10.1007/s11515-014-1337-8 42
The results show that all test compounds (8a-8z) showed significant xanthine oxidase inhibitory efficacy (Zhang et al., 2019)
Paying close attention to cardio-kidney benefits and implications for integrated CKM care models